have showed that C-MYC drived SCLC subtype evolution via reprogramming neuroendocrine peculiarity, which revealed a conserved trajectory from neuroendocrine to non-neuroendocrine subtypes, and a molecular evolution from ASCL1+ to NEUROD1+ to YAP1+ subtypes [6]. Here, ASCL1 is linked to small cell lung carcinoma.